Cost of diabetes mellitus type 1 treatment: difficulties of the families

被引:4
|
作者
Vintimilla Castro, Amparito del Rocio [1 ]
Alves Grossi, Sonia Aurora [2 ]
机构
[1] Univ Sao Paulo, Fac Med, Hosp Clin, Inst Crianca, Sao Paulo, Brazil
[2] Univ Sao Paulo, Escola Enfermagem, Surg Med Nursing Dept, Sao Paulo, Brazil
关键词
Cost of illness; Diabetes Mellitus/economics; Residential treatment/economics;
D O I
10.1590/S0103-21002008000400014
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objectives: To know the family income of diabetic patients and the places where they acquire/purchase the syringes, and to analyze the cost of treating the disease at home and the consequences of such costs. Methods: Descriptive, analytical, cross-section study, which interviewed 199 patients cared for at a large pediatric school hospital in Sao Paulo in 2004. Results: The predominant family income varied between one and two times the minimum wage (48.8%). Materials to apply insulin were acquired/purchased at the pharmacy (56.3%) and the Basic Healthcare Units (25.1%). The population would spend from R$ 20.00 to R$ 79.00 (US$ 8 to US$ 27) in syringes every month. Conclusion: Patients and guardians were forced to reuse the syringes in 76.8% of the cases to decrease their expenditure with the disease, making this a common practice in diabetes treatment.
引用
收藏
页码:624 / 628
页数:5
相关论文
共 50 条
  • [41] Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes Mellitus
    Jana Katuchova
    Denisa Harvanova
    Timea Spakova
    Rastislav Kalanin
    Daniel Farkas
    Peter Durny
    Jan Rosocha
    Jozef Radonak
    Daniel Petrovic
    Dario Siniscalco
    Meirigeng Qi
    Miroslav Novak
    Peter Kruzliak
    Endocrine Pathology, 2015, 26 : 95 - 103
  • [42] Predictors of adherence to treatment in children with type 1 diabetes mellitus
    Pastor Rodriguez, Jesus David
    ENFERMERIA CLINICA, 2007, 17 (06): : 332 - 333
  • [43] Type 1 diabetes mellitus caused by treatment with interferon-β
    Kado, S
    Miyamoto, J
    Komatsu, N
    Iwaki, Y
    Ozaki, H
    Taguchi, H
    Kure, M
    Sarashina, G
    Watanabe, T
    Katsura, Y
    Nemoto, Y
    Noritake, M
    Matsuoka, T
    INTERNAL MEDICINE, 2000, 39 (02) : 146 - 149
  • [44] Prevention and treatment of hypoglycaemia unawareness in type 1 diabetes mellitus
    Bolli, GB
    ACTA DIABETOLOGICA, 1998, 35 (04) : 183 - 193
  • [45] Advances in the Pathogenesis and Treatment Strategies for Type 1 Diabetes Mellitus
    Du, Meiheng
    Li, Sihong
    Jiang, Jun
    Ma, Xiang
    Liu, Lu
    Wang, Tao
    Zhang, Jufang
    Niu, Dong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 148
  • [46] The use of leptin as treatment for type 1 diabetes mellitus: counterpoint
    Wasserfall, Clive H.
    Mathews, Clayton E.
    Schatz, Desmond A.
    PEDIATRIC DIABETES, 2012, 13 (01) : 74 - 76
  • [47] Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes Mellitus
    Katuchova, Jana
    Harvanova, Denisa
    Spakova, Timea
    Kalanin, Rastislav
    Farkas, Daniel
    Durny, Peter
    Rosocha, Jan
    Radonak, Jozef
    Petrovic, Daniel
    Siniscalco, Dario
    Qi, Meirigeng
    Novak, Miroslav
    Kruzliak, Peter
    ENDOCRINE PATHOLOGY, 2015, 26 (02) : 95 - 103
  • [49] Polymorphism of the SDF-1 chemokine gene in Brazilian families with type 1 diabetes mellitus
    Volpini, WMG
    Testa, GV
    Persoli, LBL
    Dib, AS
    Timsit, J
    Dubois-Laforgue, D
    Caillat-Zucman, S
    TISSUE ANTIGENS, 2002, 59 : 17 - 17
  • [50] Type 1 diabetes mellitus
    Anastasia Katsarou
    Soffia Gudbjörnsdottir
    Araz Rawshani
    Dana Dabelea
    Ezio Bonifacio
    Barbara J. Anderson
    Laura M. Jacobsen
    Desmond A. Schatz
    Åke Lernmark
    Nature Reviews Disease Primers, 3